Company Filing History:
Years Active: 2012
Title: Nathalie Vigneron: Innovator in Cancer Research
Introduction
Nathalie Vigneron is a prominent inventor based in Brussels, Belgium. She has made significant contributions to the field of cancer research, particularly through her innovative work on antigenic peptides.
Latest Patents
Nathalie Vigneron holds a patent for "MAGE-C2 antigenic peptides and uses thereof." This invention relates to isolated peptides derived from MAGE-C2, nucleic acid molecules that encode MAGE-C2, and the isolated peptides derived from MAGE-C2. It also includes expression vectors comprising the nucleic acid molecules, host cells transformed or transfected with these nucleic acid molecules or expression vectors, and tetramers comprising the peptides, HLA molecules, β2-microglobulin, and a first and second binding partner. Furthermore, this invention encompasses methods for utilizing the peptides, nucleic acid molecules, expression vectors, tetramers, and complexes, as well as cytolytic T cells that recognize the peptides in complex with an HLA molecule.
Career Highlights
Nathalie Vigneron is affiliated with the Ludwig Institute for Cancer Research Limited, where she continues her groundbreaking work. Her research focuses on the development of novel cancer immunotherapies, leveraging her expertise in peptide-based technologies.
Collaborations
Some of her notable coworkers include Wenbin Ma and Benoit Van Den Eynde, who collaborate with her on various research projects aimed at advancing cancer treatment.
Conclusion
Nathalie Vigneron's contributions to cancer research through her innovative patents and collaborations highlight her role as a leading inventor in the field. Her work continues to pave the way for new therapeutic approaches in oncology.